• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Treatment of necrobiosis lipoidica with etanercept and adalimumab.

作者信息

Zhang Kevin S, Quan Long T, Hsu Sylvia

机构信息

Baylor College of Medicine, Houston, Texas, USA.

出版信息

Dermatol Online J. 2009 Dec 15;15(12):12.

PMID:20040262
Abstract
摘要

相似文献

1
Treatment of necrobiosis lipoidica with etanercept and adalimumab.用依那西普和阿达木单抗治疗类脂质渐进性坏死。
Dermatol Online J. 2009 Dec 15;15(12):12.
2
Treatment of necrobiosis lipoidica with the tumor necrosis factor antagonist etanercept.使用肿瘤坏死因子拮抗剂依那西普治疗类脂质渐进性坏死。
J Am Acad Dermatol. 2006 Mar;54(3 Suppl 2):S120-1. doi: 10.1016/j.jaad.2005.11.1042.
3
Adalimumab vs. etanercept in psoriasis.阿达木单抗与依那西普治疗银屑病的对比
Clin Exp Dermatol. 2007 Sep;32(5):593. doi: 10.1111/j.1365-2230.2007.02494.x.
4
Paradoxical worsening of psoriasis when switching from etanercept to adalimumab: a case series.从依那西普转换为阿达木单抗时出现银屑病的矛盾性恶化：病例系列。
J Dermatolog Treat. 2011 Apr;22(2):75-8. doi: 10.3109/09546630903559814. Epub 2010 Jun 5.
5
Generalized necrobiosis lipoidica treated with a combination of split-thickness autografting and immunomodulatory therapy.采用分层自体皮移植和免疫调节疗法联合治疗泛发性类脂质渐进性坏死。
Int J Dermatol. 2004 Nov;43(11):852-4. doi: 10.1111/j.1365-4632.2004.02120.x.
6
Recalcitrant cutaneous sarcoidosis responding to adalimumab but not to etanercept.对阿达木单抗有反应但对依那西普无反应的顽固性皮肤结节病。
Clin Exp Dermatol. 2010 Oct;35(7):795-6. doi: 10.1111/j.1365-2230.2010.03829.x.
7
TNF blocker drugs used to fight inflammation go head-to-head. Adalimumab had highest treatment response and remission rates, etanercept has longest drug survival rates; infliximab placed third.用于对抗炎症的肿瘤坏死因子阻滞剂药物正面交锋。阿达木单抗的治疗反应率和缓解率最高，依那西普的药物生存率最长；英夫利昔单抗位居第三。
Duke Med Health News. 2010 Mar;16(3):3.
8
Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris.比较阿达木单抗、依那西普和英夫利昔单抗治疗寻常型银屑病患者的药物生存率。
Br J Dermatol. 2011 May;164(5):1091-6. doi: 10.1111/j.1365-2133.2011.10213.x. Epub 2011 Apr 11.
9
Adalimumab treats psoriasis in patients previously treated with etanercept: a case series.
J Am Acad Dermatol. 2009 Jul;61(1):158-60. doi: 10.1016/j.jaad.2008.12.036.
10
Advertisements for TNF Inhibitors.
Med Lett Drugs Ther. 2008 Nov 17;50(1299):89.

引用本文的文献

1
Monoclonal Antibodies in the Management of Inflammation in Wound Healing: An Updated Literature Review.单克隆抗体在伤口愈合炎症管理中的应用：文献综述更新
J Clin Med. 2024 Jul 12;13(14):4089. doi: 10.3390/jcm13144089.
2
Shedding Light on Photodynamic Therapy in the Treatment of Necrobiosis Lipoidica: A Multicenter Real-Life Experience.探讨光动力学疗法治疗类脂质渐进性坏死：多中心真实世界经验。
Int J Mol Sci. 2024 Mar 23;25(7):3608. doi: 10.3390/ijms25073608.
3
Perforating necrobiosis lipoidica: good response to adalimumab.穿通性类脂质渐进性坏死：对阿达木单抗反应良好。
An Bras Dermatol. 2019 Nov-Dec;94(6):769-771. doi: 10.1016/j.abd.2019.04.003. Epub 2019 Nov 4.
4
The role of anti-tumour necrosis factor in wound healing: A case report of refractory ulcerated necrobiosis lipoidica treated with adalimumab and review of the literature.抗肿瘤坏死因子在伤口愈合中的作用：阿达木单抗治疗难治性溃疡性类脂质渐进性坏死的病例报告及文献综述
SAGE Open Med Case Rep. 2019 Oct 18;7:2050313X19881594. doi: 10.1177/2050313X19881594. eCollection 2019.
5
Granulomatous skin disease with a histological pattern of palisading granuloma - an atypical facial necrobiosis lipoidica or more?具有栅栏状肉芽肿组织学模式的肉芽肿性皮肤病——是不典型面部类脂质渐进性坏死还是其他情况？
Postepy Dermatol Alergol. 2017 Dec;34(6):618-621. doi: 10.5114/ada.2017.72468. Epub 2017 Dec 31.
6
Ulcerative necrobiosis lipoidica in the setting of anti-tumor necrosis factor-α and hydroxychloroquine treatment for rheumatoid arthritis.抗肿瘤坏死因子-α及羟氯喹治疗类风湿关节炎时出现的脂膜炎样坏死性溃疡
JAAD Case Rep. 2017 Mar 12;3(2):127-130. doi: 10.1016/j.jdcr.2017.01.006. eCollection 2017 Mar.
7
Treatment Modalities of Necrobiosis Lipoidica: A Concise Systematic Review.类脂质渐进性坏死的治疗方式：简明系统评价
Dermatol Reports. 2015 Jun 8;7(2):5749. doi: 10.4081/dr.2015.5749. eCollection 2015 May 21.
8
Ulcerated necrobiosis lipoidica as a rare cause for chronic leg ulcers: case report series of ten patients.溃疡性类脂质渐进性坏死作为慢性腿部溃疡的罕见病因：10例患者的病例报告系列
Int Wound J. 2015 Oct;12(5):548-54. doi: 10.1111/iwj.12159. Epub 2013 Oct 7.
9
[Successful treatment of a patient with ulcerated necrobiosis lipoidica non diabeticorum with adalimumab].[用阿达木单抗成功治疗一名非糖尿病性溃疡性类脂质渐进性坏死患者]
Hautarzt. 2013 Jul;64(7):509-11. doi: 10.1007/s00105-013-2535-z.
10
Ulcerative Necrobiosis Lipoidica: Is There a Place for Anti-TNFα Treatment?脂膜炎样坏死性溃疡：抗TNFα治疗是否可行？
Case Rep Med. 2012;2012:854738. doi: 10.1155/2012/854738. Epub 2012 May 23.